18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study
NACompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
November 30, 2015
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
Conditions
Amyloid PET Imaging
Interventions
DEVICE
18F-Florbetaben PET
Trial Locations (1)
54511
CHRU Nancy, Vandœuvre-lès-Nancy
All Listed Sponsors
lead
Central Hospital, Nancy, France
OTHER
NCT02556502 - 18F-Florbetaben PET Amyloid Imaging in Case of Intermediate CSF Biology for the Diagnosis of Alzheimer's Disease : a Pilot Study | Biotech Hunter | Biotech Hunter